Pathway enrichment analysis of the targets further demonstrated that diverse pathways crucial for the BC pathology were significantly enriched with the FDY003 targets, involving the PI3K-Akt, MAPK, focal adhesion, FoxO, TNF, and estrogen signaling pathways. The gene discussed is AKT1; the disease is breast cancer.